Reviva Pharmaceuticals Holdings, Inc. (RVPH)

RVPH Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	8	33	84	144	87	40
Market Cap Growth	-83.49%	-61.33%	-41.36%	65.49%	115.01%	-49.95%
Enterprise Value	-14	19	79	139	64	7
Last Close Price	0.61	5.58	36.20	103.00	85.00	57.80
PB Ratio	0.46	3.77	103.76	25.14	10.35	1.41
P/TBV Ratio	0.46	3.77	103.76	25.14	10.35	1.41
Debt / Equity Ratio	0.01	0.05	0.56	-	-	-
Net Debt / Equity Ratio	-1.26	-1.62	-16.02	-4.09	-2.21	-1.03
Net Debt / EBITDA Ratio	-	-	-	-	-	2.94
Quick Ratio	3.63	1.99	0.92	1.36	1.86	12.66
Current Ratio	3.85	2.08	1.01	1.38	1.90	13.39
Return on Equity (ROE)	-256.20%	-419.97%	-916.17%	-556.38%	-152.43%	-49.91%
Return on Assets (ROA)	-69.09%	-80.35%	-98.20%	-115.85%	-70.11%	-31.45%
Return on Capital Employed (ROCE)	-97.10%	-233.60%	-3416.10%	-605.40%	-315.00%	-34.80%
Earnings Yield	-207.17%	-60.93%	-35.49%	-27.31%	-32.53%	-21.09%
Buyback Yield / Dilution	-147.07%	-114.96%	-41.84%	-21.94%	-31.95%	-383.10%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error